The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Cancer Biopsy Market Research Report 2025

Global Cancer Biopsy Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1913010

No of Pages : 94

Ask Your Query

Synopsis

For most types of cancer, biopsy is the main way doctors diagnose cancer. A biopsy is a microscopic examination of a small amount of tissue. Other tests may indicate that cancer exists, but only biopsy can make a definite diagnosis.

The global Cancer Biopsy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Cancer Biopsy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Cancer Biopsy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Cancer Biopsy in Breast Cancer is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Cancer Biopsy include Qiagen N.V., Illumina, Inc., ANGLE Plc, Myriad Genetics, Hologic, Inc., Biocept, Inc., Thermo Fisher Scientific, Inc., Danaher and Lucence Diagnostics Pte. Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Cancer Biopsy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Biopsy.

Report Scope

The Cancer Biopsy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cancer Biopsy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cancer Biopsy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Qiagen N.V.
  • Illumina, Inc.
  • ANGLE Plc
  • Myriad Genetics
  • Hologic, Inc.
  • Biocept, Inc.
  • Thermo Fisher Scientific, Inc.
  • Danaher
  • Lucence Diagnostics Pte. Ltd.
  • GRAIL, Inc.
  • Guardant Health
  • Exact Sciences Corporation
  • Freenome Holdings, Inc.
  • Oncimmune
  • Chronix Biomedical, Inc.
  • Personal Genome Diagnostics Inc.

Segment by Type

  • Tissue Biopsies
  • Liquid Biopsies
  • Others

Segment by Application

  • Breast Cancer
  • Colorectal Cancer
  • Cervical Cancers
  • Lung Cancers
  • Prostate Cancers
  • Skin Cancers
  • Blood Cancers
  • Kidney Cancers
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Biopsy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Biopsy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Tissue Biopsies
1.2.3 Liquid Biopsies
1.2.4 Others
1.3 Market by Application
1.3.1 Global Cancer Biopsy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Breast Cancer
1.3.3 Colorectal Cancer
1.3.4 Cervical Cancers
1.3.5 Lung Cancers
1.3.6 Prostate Cancers
1.3.7 Skin Cancers
1.3.8 Blood Cancers
1.3.9 Kidney Cancers
1.3.10 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Biopsy Market Perspective (2019-2030)
2.2 Cancer Biopsy Growth Trends by Region
2.2.1 Global Cancer Biopsy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cancer Biopsy Historic Market Size by Region (2019-2024)
2.2.3 Cancer Biopsy Forecasted Market Size by Region (2025-2030)
2.3 Cancer Biopsy Market Dynamics
2.3.1 Cancer Biopsy Industry Trends
2.3.2 Cancer Biopsy Market Drivers
2.3.3 Cancer Biopsy Market Challenges
2.3.4 Cancer Biopsy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Biopsy Players by Revenue
3.1.1 Global Top Cancer Biopsy Players by Revenue (2019-2024)
3.1.2 Global Cancer Biopsy Revenue Market Share by Players (2019-2024)
3.2 Global Cancer Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Biopsy Revenue
3.4 Global Cancer Biopsy Market Concentration Ratio
3.4.1 Global Cancer Biopsy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Biopsy Revenue in 2023
3.5 Cancer Biopsy Key Players Head office and Area Served
3.6 Key Players Cancer Biopsy Product Solution and Service
3.7 Date of Enter into Cancer Biopsy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Biopsy Breakdown Data by Type
4.1 Global Cancer Biopsy Historic Market Size by Type (2019-2024)
4.2 Global Cancer Biopsy Forecasted Market Size by Type (2025-2030)
5 Cancer Biopsy Breakdown Data by Application
5.1 Global Cancer Biopsy Historic Market Size by Application (2019-2024)
5.2 Global Cancer Biopsy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cancer Biopsy Market Size (2019-2030)
6.2 North America Cancer Biopsy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cancer Biopsy Market Size by Country (2019-2024)
6.4 North America Cancer Biopsy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Biopsy Market Size (2019-2030)
7.2 Europe Cancer Biopsy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cancer Biopsy Market Size by Country (2019-2024)
7.4 Europe Cancer Biopsy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Biopsy Market Size (2019-2030)
8.2 Asia-Pacific Cancer Biopsy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cancer Biopsy Market Size by Region (2019-2024)
8.4 Asia-Pacific Cancer Biopsy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Biopsy Market Size (2019-2030)
9.2 Latin America Cancer Biopsy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cancer Biopsy Market Size by Country (2019-2024)
9.4 Latin America Cancer Biopsy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Biopsy Market Size (2019-2030)
10.2 Middle East & Africa Cancer Biopsy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cancer Biopsy Market Size by Country (2019-2024)
10.4 Middle East & Africa Cancer Biopsy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Qiagen N.V.
11.1.1 Qiagen N.V. Company Detail
11.1.2 Qiagen N.V. Business Overview
11.1.3 Qiagen N.V. Cancer Biopsy Introduction
11.1.4 Qiagen N.V. Revenue in Cancer Biopsy Business (2019-2024)
11.1.5 Qiagen N.V. Recent Development
11.2 Illumina, Inc.
11.2.1 Illumina, Inc. Company Detail
11.2.2 Illumina, Inc. Business Overview
11.2.3 Illumina, Inc. Cancer Biopsy Introduction
11.2.4 Illumina, Inc. Revenue in Cancer Biopsy Business (2019-2024)
11.2.5 Illumina, Inc. Recent Development
11.3 ANGLE Plc
11.3.1 ANGLE Plc Company Detail
11.3.2 ANGLE Plc Business Overview
11.3.3 ANGLE Plc Cancer Biopsy Introduction
11.3.4 ANGLE Plc Revenue in Cancer Biopsy Business (2019-2024)
11.3.5 ANGLE Plc Recent Development
11.4 Myriad Genetics
11.4.1 Myriad Genetics Company Detail
11.4.2 Myriad Genetics Business Overview
11.4.3 Myriad Genetics Cancer Biopsy Introduction
11.4.4 Myriad Genetics Revenue in Cancer Biopsy Business (2019-2024)
11.4.5 Myriad Genetics Recent Development
11.5 Hologic, Inc.
11.5.1 Hologic, Inc. Company Detail
11.5.2 Hologic, Inc. Business Overview
11.5.3 Hologic, Inc. Cancer Biopsy Introduction
11.5.4 Hologic, Inc. Revenue in Cancer Biopsy Business (2019-2024)
11.5.5 Hologic, Inc. Recent Development
11.6 Biocept, Inc.
11.6.1 Biocept, Inc. Company Detail
11.6.2 Biocept, Inc. Business Overview
11.6.3 Biocept, Inc. Cancer Biopsy Introduction
11.6.4 Biocept, Inc. Revenue in Cancer Biopsy Business (2019-2024)
11.6.5 Biocept, Inc. Recent Development
11.7 Thermo Fisher Scientific, Inc.
11.7.1 Thermo Fisher Scientific, Inc. Company Detail
11.7.2 Thermo Fisher Scientific, Inc. Business Overview
11.7.3 Thermo Fisher Scientific, Inc. Cancer Biopsy Introduction
11.7.4 Thermo Fisher Scientific, Inc. Revenue in Cancer Biopsy Business (2019-2024)
11.7.5 Thermo Fisher Scientific, Inc. Recent Development
11.8 Danaher
11.8.1 Danaher Company Detail
11.8.2 Danaher Business Overview
11.8.3 Danaher Cancer Biopsy Introduction
11.8.4 Danaher Revenue in Cancer Biopsy Business (2019-2024)
11.8.5 Danaher Recent Development
11.9 Lucence Diagnostics Pte. Ltd.
11.9.1 Lucence Diagnostics Pte. Ltd. Company Detail
11.9.2 Lucence Diagnostics Pte. Ltd. Business Overview
11.9.3 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Introduction
11.9.4 Lucence Diagnostics Pte. Ltd. Revenue in Cancer Biopsy Business (2019-2024)
11.9.5 Lucence Diagnostics Pte. Ltd. Recent Development
11.10 GRAIL, Inc.
11.10.1 GRAIL, Inc. Company Detail
11.10.2 GRAIL, Inc. Business Overview
11.10.3 GRAIL, Inc. Cancer Biopsy Introduction
11.10.4 GRAIL, Inc. Revenue in Cancer Biopsy Business (2019-2024)
11.10.5 GRAIL, Inc. Recent Development
11.11 Guardant Health
11.11.1 Guardant Health Company Detail
11.11.2 Guardant Health Business Overview
11.11.3 Guardant Health Cancer Biopsy Introduction
11.11.4 Guardant Health Revenue in Cancer Biopsy Business (2019-2024)
11.11.5 Guardant Health Recent Development
11.12 Exact Sciences Corporation
11.12.1 Exact Sciences Corporation Company Detail
11.12.2 Exact Sciences Corporation Business Overview
11.12.3 Exact Sciences Corporation Cancer Biopsy Introduction
11.12.4 Exact Sciences Corporation Revenue in Cancer Biopsy Business (2019-2024)
11.12.5 Exact Sciences Corporation Recent Development
11.13 Freenome Holdings, Inc.
11.13.1 Freenome Holdings, Inc. Company Detail
11.13.2 Freenome Holdings, Inc. Business Overview
11.13.3 Freenome Holdings, Inc. Cancer Biopsy Introduction
11.13.4 Freenome Holdings, Inc. Revenue in Cancer Biopsy Business (2019-2024)
11.13.5 Freenome Holdings, Inc. Recent Development
11.14 Oncimmune
11.14.1 Oncimmune Company Detail
11.14.2 Oncimmune Business Overview
11.14.3 Oncimmune Cancer Biopsy Introduction
11.14.4 Oncimmune Revenue in Cancer Biopsy Business (2019-2024)
11.14.5 Oncimmune Recent Development
11.15 Chronix Biomedical, Inc.
11.15.1 Chronix Biomedical, Inc. Company Detail
11.15.2 Chronix Biomedical, Inc. Business Overview
11.15.3 Chronix Biomedical, Inc. Cancer Biopsy Introduction
11.15.4 Chronix Biomedical, Inc. Revenue in Cancer Biopsy Business (2019-2024)
11.15.5 Chronix Biomedical, Inc. Recent Development
11.16 Personal Genome Diagnostics Inc.
11.16.1 Personal Genome Diagnostics Inc. Company Detail
11.16.2 Personal Genome Diagnostics Inc. Business Overview
11.16.3 Personal Genome Diagnostics Inc. Cancer Biopsy Introduction
11.16.4 Personal Genome Diagnostics Inc. Revenue in Cancer Biopsy Business (2019-2024)
11.16.5 Personal Genome Diagnostics Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Cancer Biopsy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Tissue Biopsies
Table 3. Key Players of Liquid Biopsies
Table 4. Key Players of Others
Table 5. Global Cancer Biopsy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Cancer Biopsy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Cancer Biopsy Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Cancer Biopsy Market Share by Region (2019-2024)
Table 9. Global Cancer Biopsy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Cancer Biopsy Market Share by Region (2025-2030)
Table 11. Cancer Biopsy Market Trends
Table 12. Cancer Biopsy Market Drivers
Table 13. Cancer Biopsy Market Challenges
Table 14. Cancer Biopsy Market Restraints
Table 15. Global Cancer Biopsy Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Cancer Biopsy Market Share by Players (2019-2024)
Table 17. Global Top Cancer Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biopsy as of 2023)
Table 18. Ranking of Global Top Cancer Biopsy Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Cancer Biopsy Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cancer Biopsy Product Solution and Service
Table 22. Date of Enter into Cancer Biopsy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cancer Biopsy Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Cancer Biopsy Revenue Market Share by Type (2019-2024)
Table 26. Global Cancer Biopsy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Cancer Biopsy Revenue Market Share by Type (2025-2030)
Table 28. Global Cancer Biopsy Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Cancer Biopsy Revenue Market Share by Application (2019-2024)
Table 30. Global Cancer Biopsy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Cancer Biopsy Revenue Market Share by Application (2025-2030)
Table 32. North America Cancer Biopsy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Cancer Biopsy Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Cancer Biopsy Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Cancer Biopsy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Cancer Biopsy Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Cancer Biopsy Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Cancer Biopsy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Cancer Biopsy Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Cancer Biopsy Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Cancer Biopsy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Cancer Biopsy Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Cancer Biopsy Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Cancer Biopsy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Cancer Biopsy Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Cancer Biopsy Market Size by Country (2025-2030) & (US$ Million)
Table 47. Qiagen N.V. Company Detail
Table 48. Qiagen N.V. Business Overview
Table 49. Qiagen N.V. Cancer Biopsy Product
Table 50. Qiagen N.V. Revenue in Cancer Biopsy Business (2019-2024) & (US$ Million)
Table 51. Qiagen N.V. Recent Development
Table 52. Illumina, Inc. Company Detail
Table 53. Illumina, Inc. Business Overview
Table 54. Illumina, Inc. Cancer Biopsy Product
Table 55. Illumina, Inc. Revenue in Cancer Biopsy Business (2019-2024) & (US$ Million)
Table 56. Illumina, Inc. Recent Development
Table 57. ANGLE Plc Company Detail
Table 58. ANGLE Plc Business Overview
Table 59. ANGLE Plc Cancer Biopsy Product
Table 60. ANGLE Plc Revenue in Cancer Biopsy Business (2019-2024) & (US$ Million)
Table 61. ANGLE Plc Recent Development
Table 62. Myriad Genetics Company Detail
Table 63. Myriad Genetics Business Overview
Table 64. Myriad Genetics Cancer Biopsy Product
Table 65. Myriad Genetics Revenue in Cancer Biopsy Business (2019-2024) & (US$ Million)
Table 66. Myriad Genetics Recent Development
Table 67. Hologic, Inc. Company Detail
Table 68. Hologic, Inc. Business Overview
Table 69. Hologic, Inc. Cancer Biopsy Product
Table 70. Hologic, Inc. Revenue in Cancer Biopsy Business (2019-2024) & (US$ Million)
Table 71. Hologic, Inc. Recent Development
Table 72. Biocept, Inc. Company Detail
Table 73. Biocept, Inc. Business Overview
Table 74. Biocept, Inc. Cancer Biopsy Product
Table 75. Biocept, Inc. Revenue in Cancer Biopsy Business (2019-2024) & (US$ Million)
Table 76. Biocept, Inc. Recent Development
Table 77. Thermo Fisher Scientific, Inc. Company Detail
Table 78. Thermo Fisher Scientific, Inc. Business Overview
Table 79. Thermo Fisher Scientific, Inc. Cancer Biopsy Product
Table 80. Thermo Fisher Scientific, Inc. Revenue in Cancer Biopsy Business (2019-2024) & (US$ Million)
Table 81. Thermo Fisher Scientific, Inc. Recent Development
Table 82. Danaher Company Detail
Table 83. Danaher Business Overview
Table 84. Danaher Cancer Biopsy Product
Table 85. Danaher Revenue in Cancer Biopsy Business (2019-2024) & (US$ Million)
Table 86. Danaher Recent Development
Table 87. Lucence Diagnostics Pte. Ltd. Company Detail
Table 88. Lucence Diagnostics Pte. Ltd. Business Overview
Table 89. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Product
Table 90. Lucence Diagnostics Pte. Ltd. Revenue in Cancer Biopsy Business (2019-2024) & (US$ Million)
Table 91. Lucence Diagnostics Pte. Ltd. Recent Development
Table 92. GRAIL, Inc. Company Detail
Table 93. GRAIL, Inc. Business Overview
Table 94. GRAIL, Inc. Cancer Biopsy Product
Table 95. GRAIL, Inc. Revenue in Cancer Biopsy Business (2019-2024) & (US$ Million)
Table 96. GRAIL, Inc. Recent Development
Table 97. Guardant Health Company Detail
Table 98. Guardant Health Business Overview
Table 99. Guardant Health Cancer Biopsy Product
Table 100. Guardant Health Revenue in Cancer Biopsy Business (2019-2024) & (US$ Million)
Table 101. Guardant Health Recent Development
Table 102. Exact Sciences Corporation Company Detail
Table 103. Exact Sciences Corporation Business Overview
Table 104. Exact Sciences Corporation Cancer Biopsy Product
Table 105. Exact Sciences Corporation Revenue in Cancer Biopsy Business (2019-2024) & (US$ Million)
Table 106. Exact Sciences Corporation Recent Development
Table 107. Freenome Holdings, Inc. Company Detail
Table 108. Freenome Holdings, Inc. Business Overview
Table 109. Freenome Holdings, Inc. Cancer Biopsy Product
Table 110. Freenome Holdings, Inc. Revenue in Cancer Biopsy Business (2019-2024) & (US$ Million)
Table 111. Freenome Holdings, Inc. Recent Development
Table 112. Oncimmune Company Detail
Table 113. Oncimmune Business Overview
Table 114. Oncimmune Cancer Biopsy Product
Table 115. Oncimmune Revenue in Cancer Biopsy Business (2019-2024) & (US$ Million)
Table 116. Oncimmune Recent Development
Table 117. Chronix Biomedical, Inc. Company Detail
Table 118. Chronix Biomedical, Inc. Business Overview
Table 119. Chronix Biomedical, Inc. Cancer Biopsy Product
Table 120. Chronix Biomedical, Inc. Revenue in Cancer Biopsy Business (2019-2024) & (US$ Million)
Table 121. Chronix Biomedical, Inc. Recent Development
Table 122. Personal Genome Diagnostics Inc. Company Detail
Table 123. Personal Genome Diagnostics Inc. Business Overview
Table 124. Personal Genome Diagnostics Inc. Cancer Biopsy Product
Table 125. Personal Genome Diagnostics Inc. Revenue in Cancer Biopsy Business (2019-2024) & (US$ Million)
Table 126. Personal Genome Diagnostics Inc. Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Biopsy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Cancer Biopsy Market Share by Type: 2023 VS 2030
Figure 3. Tissue Biopsies Features
Figure 4. Liquid Biopsies Features
Figure 5. Others Features
Figure 6. Global Cancer Biopsy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Cancer Biopsy Market Share by Application: 2023 VS 2030
Figure 8. Breast Cancer Case Studies
Figure 9. Colorectal Cancer Case Studies
Figure 10. Cervical Cancers Case Studies
Figure 11. Lung Cancers Case Studies
Figure 12. Prostate Cancers Case Studies
Figure 13. Skin Cancers Case Studies
Figure 14. Blood Cancers Case Studies
Figure 15. Kidney Cancers Case Studies
Figure 16. Others Case Studies
Figure 17. Cancer Biopsy Report Years Considered
Figure 18. Global Cancer Biopsy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 19. Global Cancer Biopsy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 20. Global Cancer Biopsy Market Share by Region: 2023 VS 2030
Figure 21. Global Cancer Biopsy Market Share by Players in 2023
Figure 22. Global Top Cancer Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biopsy as of 2023)
Figure 23. The Top 10 and 5 Players Market Share by Cancer Biopsy Revenue in 2023
Figure 24. North America Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. North America Cancer Biopsy Market Share by Country (2019-2030)
Figure 26. United States Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Canada Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Europe Cancer Biopsy Market Share by Country (2019-2030)
Figure 30. Germany Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. France Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. U.K. Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Italy Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Russia Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Nordic Countries Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Asia-Pacific Cancer Biopsy Market Share by Region (2019-2030)
Figure 38. China Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Japan Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. South Korea Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. India Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Australia Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Latin America Cancer Biopsy Market Share by Country (2019-2030)
Figure 46. Mexico Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Brazil Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Cancer Biopsy Market Share by Country (2019-2030)
Figure 50. Turkey Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Qiagen N.V. Revenue Growth Rate in Cancer Biopsy Business (2019-2024)
Figure 53. Illumina, Inc. Revenue Growth Rate in Cancer Biopsy Business (2019-2024)
Figure 54. ANGLE Plc Revenue Growth Rate in Cancer Biopsy Business (2019-2024)
Figure 55. Myriad Genetics Revenue Growth Rate in Cancer Biopsy Business (2019-2024)
Figure 56. Hologic, Inc. Revenue Growth Rate in Cancer Biopsy Business (2019-2024)
Figure 57. Biocept, Inc. Revenue Growth Rate in Cancer Biopsy Business (2019-2024)
Figure 58. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Cancer Biopsy Business (2019-2024)
Figure 59. Danaher Revenue Growth Rate in Cancer Biopsy Business (2019-2024)
Figure 60. Lucence Diagnostics Pte. Ltd. Revenue Growth Rate in Cancer Biopsy Business (2019-2024)
Figure 61. GRAIL, Inc. Revenue Growth Rate in Cancer Biopsy Business (2019-2024)
Figure 62. Guardant Health Revenue Growth Rate in Cancer Biopsy Business (2019-2024)
Figure 63. Exact Sciences Corporation Revenue Growth Rate in Cancer Biopsy Business (2019-2024)
Figure 64. Freenome Holdings, Inc. Revenue Growth Rate in Cancer Biopsy Business (2019-2024)
Figure 65. Oncimmune Revenue Growth Rate in Cancer Biopsy Business (2019-2024)
Figure 66. Chronix Biomedical, Inc. Revenue Growth Rate in Cancer Biopsy Business (2019-2024)
Figure 67. Personal Genome Diagnostics Inc. Revenue Growth Rate in Cancer Biopsy Business (2019-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock